Novo Nordisk CEO says weight-loss drug boom has barely begun [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
expanding access should be a top priority, said Mike Doustdar, the head of Novo Nordisk ( NVO ), the maker of Wegovy and Ozempic. Speaking in an interview Fresh Stock Ideas, Every Day Quick Insights Despite strong demand, only a small fraction of eligible patients currently use these drugs, leaving a large, largely untapped population. Lower prices are expected to expand access, attract a broader patient base, and benefit both Novo and policymakers. Novo's strategy is to use pricing flexibility, brand reputation, and partnerships to stay competitive despite generics entering markets, especially in cost-sensitive and underdeveloped regions. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks [Seeking Alpha]Seeking Alpha
- Aspect Biosystems receives funding for cellular medicine project [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight [Yahoo! Finance]Yahoo! Finance
- Asian travelers seek respite in other options as Middle East travel plans stay grounded Share Share VIDEO 9:54 09:54 How will Middle East flight disruptions and FX moves affect tourism in Asia? [CNBC]CNBC
- Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website